IDH1 and glioblastoma: As shown in Figures S2, in the TCGA set, patients with higher risk score tend to be older than 40 years, to have higher WHO grade, unmethylated MGMT promoter, glioblastoma, non‐codeletion of 1p/19q and wild type IDH1 (all p < 0.001).